Merck Serono and Actavis Join Forces at Pharmaceutical Anti-Counterfeiting to Brainstorm How to Ensure Patient Safety

Add bookmark

Pharma IQ News
01/05/2011

Mark Edwards, Global Freight Manager from Actavis and John Franks, Security Director EMEA from Merck Sharp & Dohme, joined forces in order to explore how patient safety could be improved by protecting pharmacies and distributors from supply chain infiltration.

Their presentation will be part of the 2nd annual Pharmaceutical Anti-Counterfeiting conference taking place in Amsterdam, from the 16th -17th of February 2011. The aim of the event is to tackle the growing problem of pharmaceutical counterfeiting. Recent figures from the EU Commission show that in 2009 alone almost 12 million pharmaceutical articles were seized by customs agencies at the external EU border; 10% of all seizures.

The event will facilitate the latest counterfeit-busting strategies, techniques and technology, with new case studies from world-leading pharmaceutical companies and presentations on the latest in innovative anti-counterfeiting technology.
[inlinead]
Other key topics include:

-Protecting your product in emerging and mature markets through learning from experiences, expertise and case studies from other pharmaceutical manufacturers (Merck, Novartis, Sanofi-Aventis, GlaxoSmithKline, Boehringer-Ingelheim, Actavis and Merck Serono)
-Tackling the latest threat of product diversion with a new case study from John Franks, Security Director EMEA, Merck, Sharp & Dohme
-Streamlining IP enforcement by working together with customs to effectively find and take down infringers (German Customs, Dutch Customs and Europol)
-Successfully implementing serialisation with the latest updates and experiences from EFPIA representative (Global and European Serialisation Lead, GlaxoSmithKline)

The full agenda, podcast, articles and interviews, are available on www.pharmaceuticalanticounterfeiting.com.

The Pharmaceutical Anti-Counterfeiting LinkedIn group is open for membership at http://events.linkedin.com/Pharmaceutical-Anti-Counterfeiting/pub/476121